Our Area of Interest
Market Presence - Engaged in Various Ways
Grünenthal‘s home market is the European Union, coverage approx. 95 %. Furthermore we have a strong presence in Latin America and are setting up our own business in Australia.
Beside our strong interest in Pain Relief Therapies Grünenthal is engaged in
- Cystic Fibrosis products in various European countries
- CNS products in Spain and Portugal
- Dermatology products in Italy
- Gynaecology with focus on oral contraceptives in Latin America
R&D Cooperations - Successful together
We are passionate about being the innovators in Pain Relief Therapies by means of world leadership in R&D for pain therapies. We are committed to develop ethical and innovative prescription pharmaceuticals with significant advancement for patients.
Global Preclinical R&D
Global Clinical Development at Grünenthal is focused on providing new options for the treatment of pain. It is engaged in all development steps of a new compound from the transition of pre-clinical research to the preparation of the dossier for marketing authorization approval providing multidisciplinary scientific and operational input.
Global Clinical Development